Literature DB >> 21555062

Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation.

Florian A Brackmann1, Alexander Kiefer, Abbas Agaimy, Martin Gencik, Regina Trollmann.   

Abstract

Lafora disease is a fatal, autosomal recessive form of progressive myoclonus epilepsy. Patients characteristically exhibit myoclonic and tonic-clonic seizures and cognitive impairment, beginning in their second decade. Alterations in two genes were identified as the cause of the disease. Mutations in the NHL repeat containing 1 (NHLRC1) gene were described in association with a more benign clinical course and later age of death, compared with epilepsy progressive myoclonus type 2A (EPM2A) mutations. We describe a rapidly progressive phenotype of Lafora disease in an adolescent patient with a novel NHLRC1 mutation. He developed severe disability and dementia less than 2 years after the onset of signs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555062     DOI: 10.1016/j.pediatrneurol.2011.01.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

Review 2.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

Review 3.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

4.  Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.

Authors:  Luca Vignatelli; Francesca Bisulli; Federica Pondrelli; Lorenzo Muccioli; Laura Licchetta; Barbara Mostacci; Corrado Zenesini; Paolo Tinuper
Journal:  Orphanet J Rare Dis       Date:  2021-08-16       Impact factor: 4.123

5.  Are c.436G>A mutations less severe forms of Lafora disease? A case report.

Authors:  Hélène-Marie Lanoiselée; Pierre Genton; Gaetan Lesca; Florence Brault; Bertrand De Toffol
Journal:  Epilepsy Behav Case Rep       Date:  2014-01-19

Review 6.  Genetics of Lafora progressive myoclonic epilepsy: current perspectives.

Authors:  Miljana Kecmanović; Milica Keckarević-Marković; Dušan Keckarević; Galina Stevanović; Nebojša Jović; Stanka Romac
Journal:  Appl Clin Genet       Date:  2016-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.